Svelte Medical Hits All Endpoints

The results for DIRECT II, a clinical trial testing Svelte Medical’s new approach to stenting, was reported in conjunction with TCT.  The Integrated Delivery System the company developed for coronary stent placement was being tested in Europe.  The trial hit all of its clinical endpoints, including reduced procedure time.  It’s always nice to highlight technologies that can provide great care while simultaneously reducing the needs of the overall healthcare system.